CDKN2A Antibody

• NCBI Gene ID:

  1029

• Swiss Prot:

  P42771

• Accession Number:

  NP_478104.1

• Host:

  Goat

• Reactivity:

  Human

• Immunogen:

  The immunogen for this antibody is: C-ILRKKGRLPGEFSE

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Signal Transduction, Homeostasis, Cancer

• Purification:

  Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

• Concentration:

  500 ug/mL

• Buffer:

  Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Aliquot and store at -20˚ C. Minimize freezing and thawing.

• Specificity:

  This antibody is expected to recognize the pancreas isoform (NP_478104.1) only.

• Applications Notes:

  Peptide ELISA: Western Blot:

• Symbol:

  CDKN2A

• NCBI Official Name:

  Cyclin-dependent kinase inhibitor 2A

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Normand G, Hemmati PG, Verdoodt B, von Haefen C, Wendt J, Guner D, May E, Dorken B, Daniel PT. p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity. J Biol Chem. 2005 Feb 25;280 (8) :7118-30. Epub 2004 Dec 6.

• Other Product Names:

  CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), HGNC:1787, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19 , CDK4 inhibitor p16-INK4, cell cycle negative regulator beta, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A, p14ARF, cyclin-dependent kinase inhibitor p12, p16INK4a alternatively spliced form, cyclin-dependent kinase inhibitor p16, multiple tumor suppressor 1

• Tested Applications:

  ELISA, WB

• Protein ID:

  17738298

• Physical Properties:

  Liquid